s6y

Greenland Mines Ltd

Ticker
GRML, GRMLW
CIK
1907223
Industry
Biological Products, (No Diagnostic Substances)
Formerly
Klotho Neurosciences, Inc., ANEW Medical, Inc., Redwoods Acquisition Corp.

Financials 34

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q/A Quarterly Report for period ending Mar 31, 2026
  4. 10-K/A Annual Report for period ending Dec 31, 2025
  5. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2026
  6. 10-Q Quarterly Report for period ending Mar 31, 2026
  7. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2026
  8. 10-K Annual Report for period ending Dec 31, 2025
  9. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  10. 10-Q Quarterly Report for period ending Sep 30, 2025

All 34 financials filings

News 83

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 83 news filings

Ownership 43

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 43 ownership filings

Prospectus 49

  1. S-1 General form of registration statement for all companies including face-amount certificate companies
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 49 prospectus filings

Proxies 18

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEFR14A Definitive revised proxy soliciting materials
  6. DEF 14A Definitive proxy statements
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14A Definitive proxy statements
  10. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

All 18 proxies filings

Other 45

  1. SCHEDULE 13G/A
  2. SCHEDULE 13G
  3. EFFECT Notice of Effectiveness
  4. 144 Filing for proposed sale of securities under Rule 144
  5. SCHEDULE 13G
  6. 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
  7. 144 Filing for proposed sale of securities under Rule 144
  8. SCHEDULE 13G
  9. EFFECT Notice of Effectiveness
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 45 other filings